120 related articles for article (PubMed ID: 17454426)
1. Effect of process variables on particle size and viability of Bifidobacterium lactis Bb-12 in genipin-gelatin microspheres.
Annan NT; Borza A; Moreau DL; Allan-Wojtas PM; Hansen LT
J Microencapsul; 2007 Mar; 24(2):152-62. PubMed ID: 17454426
[TBL] [Abstract][Full Text] [Related]
2. Microencapsulation in genipin cross-linked gelatine-maltodextrin improves survival of Bifidobacterium adolescentis during exposure to in vitro gastrointestinal conditions.
Borza AD; Annan NT; Moreau DL; Allan-Wojtas PM; Ghanem A; Rousseau D; Paulson AT; Hansen LT
J Microencapsul; 2010; 27(5):387-99. PubMed ID: 19860547
[TBL] [Abstract][Full Text] [Related]
3. Genipin-crosslinked gelatin microspheres as a drug carrier for intramuscular administration: in vitro and in vivo studies.
Liang HC; Chang WH; Lin KJ; Sung HW
J Biomed Mater Res A; 2003 May; 65(2):271-82. PubMed ID: 12734822
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of characteristics between glutaraldehyde- and genipin-crosslinked gelatin microspheres].
Li M; Liu X; Liu X
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Jan; 23(1):87-91. PubMed ID: 19192887
[TBL] [Abstract][Full Text] [Related]
5. Effect of process variables on particle size of gelatin microspheres containing lactic acid.
Dinarvand R; Mahmoodi S; Farboud E
Pharm Dev Technol; 2004 Aug; 9(3):291-9. PubMed ID: 15458234
[TBL] [Abstract][Full Text] [Related]
6. Gelatin microspheres crosslinked with genipin for local delivery of growth factors.
Solorio L; Zwolinski C; Lund AW; Farrell MJ; Stegemann JP
J Tissue Eng Regen Med; 2010 Oct; 4(7):514-23. PubMed ID: 20872738
[TBL] [Abstract][Full Text] [Related]
7. Microencapsulation of isoniazid in genipin-crosslinked gelatin-A-κ-carrageenan polyelectrolyte complex.
Devi N; Maji TK
Drug Dev Ind Pharm; 2010 Jan; 36(1):56-63. PubMed ID: 19681667
[TBL] [Abstract][Full Text] [Related]
8. Formulation and evaluation of flurbiprofen-loaded genipin cross-linked gelatin microspheres for intra-articular delivery.
Kawadkar J; Jain R; Kishore R; Pathak A; Chauhan MK
J Drug Target; 2013 Feb; 21(2):200-10. PubMed ID: 23249324
[TBL] [Abstract][Full Text] [Related]
9. Chitosan-genipin microspheres for the controlled release of drugs: clarithromycin, tramadol and heparin.
Harris R; Lecumberri E; Heras A
Mar Drugs; 2010 May; 8(6):1750-62. PubMed ID: 20631867
[TBL] [Abstract][Full Text] [Related]
10. Genipin-crosslinked gelatin microspheres as a strategy to prevent postsurgical peritoneal adhesions: In vitro and in vivo characterization.
De Clercq K; Schelfhout C; Bracke M; De Wever O; Van Bockstal M; Ceelen W; Remon JP; Vervaet C
Biomaterials; 2016 Jul; 96():33-46. PubMed ID: 27135715
[TBL] [Abstract][Full Text] [Related]
11. Formation of model hepatocellular aggregates in a hydrogel scaffold using degradable genipin crosslinked gelatin microspheres as cell carriers.
Lau TT; Lee LQ; Leong W; Wang DA
Biomed Mater; 2012 Dec; 7(6):065003. PubMed ID: 23117748
[TBL] [Abstract][Full Text] [Related]
12. Electrospun gelatin nanofibers: optimization of genipin cross-linking to preserve fiber morphology after exposure to water.
Panzavolta S; Gioffrè M; Focarete ML; Gualandi C; Foroni L; Bigi A
Acta Biomater; 2011 Apr; 7(4):1702-9. PubMed ID: 21095244
[TBL] [Abstract][Full Text] [Related]
13. Stabilization of gelatin films by crosslinking with genipin.
Bigi A; Cojazzi G; Panzavolta S; Roveri N; Rubini K
Biomaterials; 2002 Dec; 23(24):4827-32. PubMed ID: 12361622
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of genipin-cross-linked silk fibroin/chitosan sustained-release microspheres.
Zeng S; Ye M; Qiu J; Fang W; Rong M; Guo Z; Gao W
Drug Des Devel Ther; 2015; 9():2501-14. PubMed ID: 25999693
[TBL] [Abstract][Full Text] [Related]
15. Influence of processing variables on the properties of gelatin microspheres prepared by the emulsification solvent extraction technique.
Ugwoke MI; Kinget R
J Microencapsul; 1998; 15(3):273-81. PubMed ID: 9608392
[TBL] [Abstract][Full Text] [Related]
16. Growth factor sequestration and enzyme-mediated release from genipin-crosslinked gelatin microspheres.
Turner PA; Thiele JS; Stegemann JP
J Biomater Sci Polym Ed; 2017 Nov; 28(16):1826-1846. PubMed ID: 28696181
[TBL] [Abstract][Full Text] [Related]
17. Gelatin microspheres encapsulated with a nonpeptide angiogenic agent, ginsenoside Rg1, for intramyocardial injection in a rat model with infarcted myocardium.
Wei HJ; Yang HH; Chen CH; Lin WW; Chen SC; Lai PH; Chang Y; Sung HW
J Control Release; 2007 Jul; 120(1-2):27-34. PubMed ID: 17532519
[TBL] [Abstract][Full Text] [Related]
18. Effects of salt addition on the microencapsulation of proteins using W/O/W double emulsion technique.
Pistel KF; Kissel T
J Microencapsul; 2000; 17(4):467-83. PubMed ID: 10898087
[TBL] [Abstract][Full Text] [Related]
19. Creation of macroporous calcium phosphate cements as bone substitutes by using genipin-crosslinked gelatin microspheres.
Li M; Liu X; Liu X; Ge B; Chen K
J Mater Sci Mater Med; 2009 Apr; 20(4):925-34. PubMed ID: 19052846
[TBL] [Abstract][Full Text] [Related]
20. Preparation of genipin cross-linked chitosan-gelatin microcapsules for encapsulation of Zanthoxylum limonella oil (ZLO) using salting-out method.
Hussain MR; Maji TK
J Microencapsul; 2008 Sep; 25(6):414-20. PubMed ID: 18465294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
